We provide end-to-end pharmaceutical consulting services to embrace the rich potential that emerging markets hold for Western pharma companies.

While Big Pharma is in a global search for available quality healthcare resources, regulators are raising the level of scrutiny applied to medical device and drug certification processes. Thus, while the potential of emerging markets is clear, there are often considerable challenges. Complex legislation and regulation; a volatile, rapidly-changing environment; and scarcity of reliable information can all pose serious obstacles to commercial success. Local insight can be crucial to the development of effective strategies and efficient execution. We combine local, on-the-ground expertise with real business acumen, to deliver optimal solutions for our clients. We’re here to help you make informed and reliable go/no-go decisions.

The comprehensive range of fully-customizable pharmaceutical consulting solutions we offer at Raifarm have been developed to help international sponsors meet certification requirements and use their time, money, and human resources in the most efficient and effective ways possible.

  • Pharma Market Analysis. International companies looking to enter emerging markets are often frustrated by market data that’s incomplete, unreliable, or contradictory – or simply unavailable. Raifarm draws on its deep expertise of local pharmaceutical markets, extensive personal networks, and proprietary knowledge database to offer clear, accurate, pertinent information to enable rapid, effective action that delivers results. We routinely survey all markets in which we operate, and have undertaken over 35 bespoke healthcare market analysis projects for leading Western companies, covering both new product launches and line-extensions.
  • Strategic Advisory. Good strategic advice is never at a greater premium than in emerging pharma markets. Yet, few global consulting firms have any great experience or expertise in the pharmaceutical industry, with all its specialization and complexity. Our team’s decades of combined industry experience enable us to fully understand our clients’ needs and offer reliable, practical, and actionable solutions. We advise across a wide range of strategic and operational issues, across a multitude of geographic areas. The numerous consulting projects we have successfully completed range from the creation of a CIS market entrance strategy, to drug portfolio optimization; from medical device consulting and assessment of distribution systems, to localized evaluation for business development opportunities.
  • In-Licensing Support. Our employees’ exceptionally strong knowledge of various therapeutic areas and available medicines enables us to pinpoint promising molecules with strong commercial potential. We then help our clients source them and work to negotiate the best possible terms. We also maintain a database of selected molecules, which we offer to our clients based on their needs and existing portfolios.
  • Custom Projects. Our broad expertise enables us to offer our clients a wide range of other, custom-tailored advisory services, helping them meet even the most demanding strategic and operational challenges. Through process optimization, we reduce time expenditures and bring all other pertaining expenses to the lowest possible amounts, offering cutting-edge customized logistical solutions.

We help developers to navigate the sophisticated regulatory regimes in Russia, CIS, and throughout Europe. Our expertise ensures clients make progressive, well-informed decisions by integrating our vast knowledge into their operational strategies – to provide reliable outsourcing solutions for the ever-evolving healthcare landscape.